EXEL Stock Analysis: Buy, Sell, or Hold?
EXEL - Exelixis Inc
$50.90
-0.39 (-0.76%)
▼
5d:
+10.15%
30d:
+14.95%
90d:
+19.2%
HOLD
MODERATE Confidence
Analysis Updated: May 13, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Distribution
EXEL is up 5.8% this week, but smart money is buying puts. Top strike: $40 2026-06-18 with 62 OI. Put ratio: 79% View Scanner →
Strength: 5.8/10
Get Alerted When EXEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called EXEL this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EXEL is fairly valued with market pricing in 2.0% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: EXEL is fairly valued with market pricing in 2.0% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$72.94
Based on 8.7% avg growth
INTRINSIC VALUE TODAY
$45.29
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EXEL is currently trading at $50.90, which is considered extended relative to its 30-day fair value range of $43.66 to $47.63. The stock's valuation (Forward PE: 12.7) is in line with its historical norms (11.9). At these levels, the market is pricing in 2.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, EXEL is in a strong downtrend. The price is approaching resistance at $51.63. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EXEL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EXEL is in a strong downtrend. The price is approaching resistance at $51.63. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EXEL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$43.66 -
$47.63
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
53.3%
Protect Your Profits
Holding EXEL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+6.9% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($49.06)
- NEUTRAL: Market pricing in 2.0% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$43.66 -
$47.63
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$43.50
Resistance Level
$51.63
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.67
Wall Street Target
$49.06
(-4.4%)
Revenue Growth (YoY)
10.0%
Earnings Growth (YoY)
43.6%
Profit Margin
35.1%
Valuation Premium vs History
+2.0% premium
PE vs Historical
12.7 vs 11.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.0%
(market-implied from PE analysis)
1-Year Target
$52.32
(+2%)
2-Year Target
$53.36
(+4%)
3-Year Target
$54.43
(+6%)
3-Yr Target (if PE normalizes)
(PE: 13→12)
PE COMPRESSION
$51.12
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 13.4%)
$130.19
(+154%)
Base:
(SPY PE: 12.7, Growth: 13.4%)
$74.84
(+46%)
Bear:
(PE: 10.8, Growth: 13.4%)
$63.62
(+24%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 16.38 | Current EPS (TTM): $3.02
Bull Case
$72.93
(+42%)
Analyst growth 34.0%, PE expands to 18.0
Base Case
$66.30
(+29%)
Market implied 34.0%, PE stable at 16.4
Bear Case
$33.63
(-34%)
Severe decline -20.0%, PE contracts to 13.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 14, 2026 11:36 AM ET
Data refreshes hourly during market hours. Next update: 12:36 PM
Data refreshes hourly during market hours. Next update: 12:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EXEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Dana Aftab
SELL
47918 shares
2026-02-24
Dana Aftab
SELL
29873 shares
2026-02-19
Brenda Hefti
SELL
18669 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$550 | 67 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 61 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 58 HOLD |
Advanced EXEL Option Strategies
Professional options setups generated by AI based on today's EXEL price and gamma walls.
